The mobility of human neutrophils (PMN) 
Cryptococcus neoformans is an encapsulated yeastlike organism which causes cryptococcosis, a chronic, subacute or (rarely) acute, pulmonary, systemic, or meningeal fungal disease. The tissue reactions in cryptococcosis vary considerably from organ to organ and from case to case. In some individuals, reactions are characterized by infiltration of macrophages and lymphocytes, whereas in others, little host tissue response has been noted (32) . When a host tissue response occurs in cryptococcosis, the first wave of infiltrating cells into the tissues containing C. neoformans is composed largely of neutrophils (PMN), as would be expected for most other inflammatory reactions (16) . Several investigators have observed that injection of C. neofonnans into the peritoneal cavity of rabbits, guinea pigs, or mice induces migration of PMN which is later followed by an influx of mononuclear cells (14, 16, 18) . PMN have been shown to have the potential to kill C. neofonnans cells by intracellular as well as extracellular mechanisms (4, 9, 16, 25) . Generally, PMN are regarded as effective components of the natural host defense system against C. neoformans.
The mechanisms by which PMN are attracted to a site of infection are complex. They involve local production of chemotactic factors that promote directed migration of PMN. Chemotactic factors that affect the influx of PMN can be products of the infecting microorganism such as bacterial formylmethionyl peptide (33) , host serum protein-derived factors such as C5a (13) , and host cell-derived factors such as interleukin-8 (34) .
Several groups of investigators have demonstrated that C. neoformans cells can activate serum factors which are * Corresponding author. chemotactic to PMN. Laxalt and Kozel (22) reported that the encapsulated yeast cells of a serotype D isolate of C. neoformans and a nonencapsulated isolate, 602, activate the alternative complement pathway in serum, generating a chemotactic factor for rabbit PMN. Diamond and Erickson (8) observed that whole cells of a C. neoformans serotype A isolate activate serum, generating CSa, which is chemotactic for human PMN. Perfect and Durack (29) found that there is a chemotactic factor for PMN in cerebrospinal fluid from rabbits with chronic cryptococcal meningitis. The latter chemotactic factor appeared to be host derived, with characteristics consistent with a lymphokine or with C5a.
The surface components of C. neoformans which might have the potential to directly stimulate chemotaxis of PMN have not been clearly defined, nor have the cryptococcal components which activate serum factors to become chemotactic been identified. The surface of encapsulated C. neoformans blastoconidia is composed predominantly of a high-molecular-weight polysaccharide described as a glucuronoxylomannan (GXM) (27) . It is possible, however, that some soluble components thought to be associated with the cryptococcal cell wall, such as the mannoprotein (MP), are exposed to the outer surface of the cryptococcal cell as well, because they are found in the culture filtrates from the organism (17, 36) . For example, a C. neoformans culture filtrate that has proved to be useful in detection of anticryptococcal delayed-type hypersensitivity is CneF. CneF prepared with cryptococcal isolate 184A (CneF-184A) has been shown to contain GXM, galactoxylomannan (GalXM), and MP (27) . In contrast, a culture filtrate prepared from an acapsular mutant of C. neofonnans isolate J67 contained only GalXM and MP and lacked GXM (27) . On the basis of our present knowledge, it seems that encapsulated isolates 5068 DONG AND MURPHY of C. neoformans most likely have exposed GXM and MP to the external environment, whereas nonencapsulated isolates have MP but lack GXM.
The main objectives of this study were to determine both what components exposed on the surface of C. neofornans can directly stimulate movement of PMN and which component(s) is responsible for activation of the complement cascade to provide chemotactic factors. To gain information concerning these questions, we first assessed whether or not C. neoformans 184A cells and soluble CneF-184A could directly stimulate movement of PMN in the absence of serum factors. Second, we determined the ability of whole 184A cells and CneF-184A to activate heat-labile components, presumably complement components in pooled human serum (PHS), to become chemotactic factors. Third, we compared the chemotactic activity of encapsulated C. neoformans 184A cells with the chemotactic activity of a nonencapsulated C. neoformans 602 isolate in the presence and absence of PHS. Fourth, we compared the chemotactic activity of the soluble antigen CneF-184A which contains GXM, GalXM, and MP with that of the soluble antigen from the acapsular isolate 602 (CneF-602) which contains components similar to those in CneF-J67, i.e., GalXM and MP (26) . Finally, we assessed the ability of purified GXM-and MP-enriched fractions from CneF-184A and MP-enriched fractions from CneF-602 to stimulate locomotion of PMN in the presence and absence of PHS.
MATERIALS AND METHODS
Performance of all experiments in endotoxin-free conditions. Endotoxin-free plastic ware (purchased, endotoxinfree) and glassware (heated at 180°C for 3 h) were used throughout the study. Media and reagents were checked for endotoxin contamination by a commercial Limulus amoebocyte lysate kit before use and were used only when they tested negative in the Limulus assay.
Organisms. C. neofornans isolate 184A is an encapsulated serotype A strain (26) , and strain 602 is a stable nonencapsulated isolate of C. neoformans obtained from Thomas Kozel (19) . Both isolates were maintained on modified Sabouraud agar slants. Heat-killed C. neoformans cells were prepared by harvesting the blastoconidia in sterile physiologic saline solution after 3 days of growth at room temperature on modified Sabouraud agar slants and incubating the organism at 60°C for 1 h. After heat treatment, the sterility of the culture was demonstrated by lack of growth on modified Sabouraud agar. The heat-killed cryptococcal cells were washed three times and resuspended in Hanks' balanced salt solution (HBSS).
Preparation and analysis of antigen. The cryptococcal culture filtrate antigens CneF-184A and CneF-602 were prepared by culturing C. neoformans 184A and 602, respectively, in a manner similar to that described by Buchanan and Murphy (3) . Briefly, yeast cells were removed from the supernatant fluids from 5-day-old cultures of C. neofonnans with a Millipore OM-141 Pellicon Tangential Flow System and a 0.45-,um-pore-size filter. The culture filtrates were washed with 10 volumes of sterile physiologic saline solution with a 30,000-molecular-weight cutoff cassette in the Pellicon System, and then the retentate was concentrated to 1/10 the original volume. The concentrated CneF was filter sterilized and stored at -20°C until used. The concentration of CneF-184A was adjusted to 2 mg of carbohydrate (CHO) per ml as determined by the phenol-sulfuric acid assay (10) and 0.13 mg of protein per ml on the basis of a bicinchoninic acid assay (Pierce Chemical Co., Rockford, Ill.). The concentration of CneF-602 was adjusted to 2 mg of CHO per ml and 0.10 mg of protein per ml as determined by the same methods designated above. CneF-184A and CneF-602 were analyzed by anodic polyacrylamide slab gel electrophoresis, as described previously by Murphy et al. (27) . The CneF-184A preparation used in these studies had banding and staining patterns on the electrophoretic gels similar to those reported previously for CneF-184A, and CneF-602 displayed banding patterns similar to those reported for CneF-J67 (27) .
Preparation of GXM and MP. When CneF-184A was subjected to gel filtration on a Sephacryl S-300 high-resolution column (5 by 100 cm; Pharmacia K column), the first CHO peak off the column contained GXM, as determined by electrophoretic mobility in 10% polyacrylamide gels (27) . The second major CHO peak from the Sephacryl S-300 column was a mixture of GalXM and MP, which was similar to the GalXM-N fraction described by Cherniak et al. (5, 27) . The fractions which represented the second major peak were pooled, concentrated, and rechromatographed on a Sephacryl S-300 column to remove any contaminating GXM. The GalXM-MP-containing peak from the second pass over the Sephacryl S-300 column appeared to be free of GXM on 10% polyacrylamide gels and was further fractionated on a concanavalin A (ConA) Sepharose 4B column (5) . The effluent from the ConA column was predominantly GalXM. MP was eluted from the ConA column with 200 mM oa-methyl-D-mannopyranoside. The GXM and MP fractions were subjected to electrophoresis to determine the efficiency of the fractionation; then GXM was lyophilized and reconstituted in HBSS to 2 mg (dry weight)/ml. The final concentration of GXM or MP in the chemotactic chamber was 0.5 mg (dry weight)/ml. The protein concentration of the MP fraction at 0.5 mg (dry weight)/ml was 0.05 mg/ml and equivalent to the protein concentration of CneF-184A diluted 1:2.6.
Preparation of PHS. Peripheral blood was collected from three volunteers. The sera were pooled and stored at -130°C. This pool was used as the source of PHS. For studies requiring heat-inactivated serum, the PHS was heated at 56°C for 30 min before use.
Isolation of human PMN. Human PMN were obtained by a method described previously (23, 37) . Briefly, buffy coats of human peripheral blood were diluted with balanced salt solution, layered on Ficoll-Hypaque, and centrifuged. The cell pellet was collected from the Ficoll-Hypaque and sedimented with 6% dextran solution for 30 min. The PMN-rich population was collected from the upper layer of the dextran solution. Residual erythrocytes were lysed with a 0.85% NH4C1 solution. PMN were washed and resuspended in HBSS before being diluted to a concentration of 4 x 106 cells per ml. The cell populations were composed of >95% PMN as determined by differential counts on Diff-Quick (Baxter Healthcare Co., Miami, Fla.)-stained smears. The viability of cells in the PMN-enriched fraction was >95% by trypan blue dye exclusion.
Chemotaxis assay. The PMN chemotaxis assay was performed by using a 48-well modified Boyden chamber (Neuro Probe, Inc., Bethesda, Md.) with a 10-,um-thick polyvinylpyrrolidone-free polycarbonate membrane of 3 ,um pore size (Nuclepore Corp., Pleasanton, Calif.). Polyvinylpyrrolidone-free membranes were used because PMN will remain on the bottom of the membrane and will not drop off into the medium below (15 
RESULTS
Direct and indirect chemotactic activity of C. neoformans 184A cells on human PMN. C. neoformans 184A cells were assessed for the ability to stimulate directed migration of PMN in the absence of PHS (direct chemotactic activity). For this, various numbers of C. neofonnans yeast cells were suspended in HBSS and placed in the lower wells of a 48-well modified Boyden chamber system, and PMN were added to the chamber above the membrane. When suspended in HBSS containing no PHS, C. neofonnans cells stimulated a greater number of PMN to migrate across the membrane than did the HBSS control (Fig. 1 , cf. 2.11 -+-0.06, the mean CI + SEM for 2.5 x 107 184A cells per ml, or 2.67 + 0.24 for 5 x 107 184A cells per ml with 1.0 for the HBSS control; n = 3; P < 0.01).
To determine whether or not C. neoformans 184A cells also could activate human serum to generate a chemotactic factor(s) for PMN (indirect chemotactic activity), various numbers of cells were incubated with 25% PHS for 30 min at 37°C, after which cryptococcal cells were removed by centrifugation. The activated serum was placed in lower wells of the chemotaxis chamber, and PMN were put in the upper wells. PHS which had not been activated with C. neofor- mans showed chemotactic activity compared with the HBSS control ( Fig. 1 , cf. 2.21 + 0.12, the mean CI + SEM for PHS, with the HBSS control value; P < 0.01). PHS activated with 2.5 x 107 to 5.0 x 107 cryptococcal 184A cells per ml displayed significantly greater chemotactic activities than did unactivated PHS samples (Fig. 1 , cf. 3.17 + 0.14 or 3.75 + 0.14, the mean CI + SEM for PHS activated with 2.5 x 107 or 5 x 107 cryptococcal cells per ml, respectively, with 2.21 + 0.12, the mean CI + SEM for PHS alone; P < 0.01).
Data collected by using PMN from six normal subjects provided further evidence that whole encapsulated cryptococcal yeast cells had direct as well as indirect chemotactic activity on human PMN (Fig. 2) . Although C. neoformans 184A cells induced chemotaxis of the human PMN, the chemotactic activity of C. neofonnans 184A cells was significantly lower than the activity of C. neoformans-activated PHS or FMLP (Fig. 2 , cf. group 1 with group 3 or 4). However, the chemotactic activity of C. neofonnans cells was similar to the activity of PHS (Fig. 2 Generation of a chemotactic factor(s) in serum by CneF-184A and effect of heating the serum. As shown in early experiments (Fig. 3) , when mixed with PHS, a 1:2 or 1:4 dilution of CneF-184A stimulated more PMN migration than did PHS or CneF-184A alone (Table 2 ). This increased chemotactic activity to CneF-184A in PHS could be due to the generation of a chemotactic factor(s) from serum components by CneF-184A or it could be due to the combined chemotactic activities of PHS and CneF-184A, which both independently displayed chemotactic activity. To distinguish between these possibilities, PHS was depleted of heat-labile complement components composed mainly of C3 by heating the PHS to 56°C for 30 min prior to assessing the chemotactic activity of the heated serum. As shown in Table 2 , heating of PHS did not reduce its chemotactic activity (Table 2, cf. 5 .0 x 107 per ml stimulated the migration of a significantly higher mean number of PMN across the membrane than was seen in the HBSS control ( Fig. 5 ; P < 0.01). These data suggest that a capsular component(s) is responsible for the direct chemotactic activity of C. neofornans for PMN. PHS activated by 5 X 107 encapsulated 184A or nonencapsulated 602 cryptococcal cells per ml induced increased migration of the PMN compared with migration in response to nonactivated PHS ( Fig. 6 ; P < 0.01). Fewer 184A cryptococcal cells than 602 cells were needed to stimulate PHS to display an increased level of chemotactic activity (Fig. 6) .
Comparison of the chemotactic activities of culture filtrates from isolates 184A (CneF-184A) and 602 (CneF-602). As shown in the earlier experiments (Fig. 4) , CneF-184A had direct chemotactic activity for human PMN (Fig. 7 , cf. group 3 with group 1; P < 0.001). In contrast, CneF-602 did not stimulate movement of the PMN across the membrane (Fig.  7 , cf. group 4 with group 1; P > 0.05). On the other hand, both CneF-184A and CneF-602 activated PHS to generate a chemotactic factor(s) (Fig. 7 , cf. group 6 or 7 with group 5; P < 0.001), and there was no significant difference in the chemotactic activity of CneF-184A in PHS and the chemotactic activity of CneF-602 in PHS (Fig. 7 , cf. group 7 with group 6; P > 0.05). As demonstrated by Murphy et al. (27) , CneF-184A contains three major constituents on the basis of the electrophoretic banding pattern in 10% polyacrylamide gels. The constituents of CneF have been designated GXM, GalXM, and MP (27) . When CneF-602 was subjected to electrophoresis in 10% polyacrylamide gels, bands equivalent to the GalXM and MP bands of CneF-184A were observed, and the GXM band was absent (data not shown). Effect of GXM on PMN migration. To obtain direct evidence on the effect of GXM on PMN migration, we purified GXM from CneF-184A and placed GXM diluted in HBSS or PHS in the lower wells of the chemotactic chambers and PMN in the upper wells. GXM was observed to stimulate PMN migration in the absence of PHS (Fig. 8 , cf. group 3 with group 1; P < 0.001). GXM in PHS also stimulated PMN migration, and the amount of PMN migration was significantly greater than with PHS or GXM alone (Fig. 8 , cf. group 5 with group 4 or 3; P < 0.001). These results indicate that GXM has both direct and indirect chemotactic activity on human PMN.
Effect of MP on PMN migration. MP is a component of both CneF-184A and CneF-602. To determine the ability of MP to mediate chemotaxis of PMN, we purified MP from CneF-184A and CneF-602 and then tested the chemotactic activities of MP-184A and MP-602 in HBSS or in PHS. MP prepared from CneF-184A or CneF-602 did not stimulate PMN migration in the absence of PHS (Fig. 9 , cf. group 4 or 3 with group 1; P > 0.05), whereas both MP-184A and MP-602 in PHS stimulated a greater number of PMN to migrate across the membrane than did PHS alone (Fig. 9 , cf. group 6 or 7 with group 5; P < 0.001). These data indicate that neither MP preparation had direct chemotactic activity, but both could activate a component(s) in PHS to become chemotactic.
DISCUSSION
The data presented here indicate that the chemotactic factors which attract directed migration of PMN to the site of infection with an encapsulated isolate of C. neoformans are from at least two sources: one is C. neoformans derived, and the other is serum derived but activated by cryptococcal components. One objective of this study was to identify the 8 (2, 5) . Culture filtrates from encapsulated C. neoformans isolates and ethanol-precipitated polysaccharides from the culture filtrates contain mainly GXM (88%, wt/wt), with small amounts of GalXM and MP (12%, wt/wt) (5, 27) . In contrast to the encapsulated cryptococci, acapsular isolates have no GXM on their surface, and culture filtrates from acapsular isolates contain no GXM but do contain GalXM and MP (17, 27) . The cellular origins of GalXM and MP are not completely clear. The available data suggest that the MP is generated on the cytosolic side of the cell wall and diffuses slowly through the wall to various extracellular sites, including the cell wall and capsule (36) . Considering that both GalXM and MP can be found in culture supernatants from encapsulated as well as acapsular isolates of C. neofonnans, it is reasonable to predict that GalXM and MP could be associated with the surface of the encapsulated as well as the acapsular cryptococcal cells. In fact, Vartivarian et al. (36) showed that fluorescein-labeled ConA binds to the surface of Cap67 C neoformans, an acapsular mutant. Since ConA binds MP but not GXM or GalXM, it is possible the fluorescein-labeled ConA was binding to MP at the surface of the cell. The data certainly suggest that MP may be exposed to the cell surface, at least in acapsular cryptococcal cells.
The component(s) of C. neoformans that directly stimulates PMN migration is associated with the capsule, since encapsulated but not acapsular C. neoformans cells induced chemotaxis of PMN in the absence of serum. In addition, we observed that the culture filtrate from the capsular isolate of C. neoformans (CneF-184A) had the same potential to directly stimulate chemotaxis of PMN as the 184A cryptococcal cells, and the culture filtrate from an acapsular isolate of C. neofonnans (CneF-602), like the 602 cells, did not directly stimulate chemotaxis of PMN. That is, CneF-184, which contains approximately 88% GXM (5), directly stimulates movement of PMN, whereas CneF-602, which contains GalXM and MP, does not. These data suggest that GXM was responsible for the direct chemotaxis observed. Final proof that GXM, the major capsular and culture filtrate constituent, was responsible for the direct chemotaxis of PMN was provided by showing that purified GXM stimulated directed movement of human PMN in the absence of serum. Thus, we conclude that GXM is the component of the cryptococcal capsule and the culture filtrate responsible for the direct chemotactic effect on human PMN.
It seems likely that GXM may have direct chemotactic activity for PMN in vivo as well as in vitro. Rhodes (31) showed that 10% of the leukocytes isolated from lungs of C5-mice at 1 h after intravenous injection of encapsulated C. neoformans were PMN, whereas under the same conditions 35% of the leukocytes isolated from lungs of C5+ mice were PMN. In addition, she found that an intraperitoneal injection of encapsulated C. neofonnans cells induced an influx of PMN into the peritoneum of C5-mice, indicating that there is a source of chemotactic factor(s) other than complement that attracts PMN to the site of a C. neoformans infection. Since it has been shown that GXM can stimulate movement of PMN in the absence of heat-labile complement factors, it is reasonable to speculate that GXM may be one of the sources of chemotactic factor(s) in the C. neoformansinfected C5-mice. However, we cannot rule out the possibility that host cell-derived factors such as chemokines or cytokines were also involved in stimulating the influx of PMN into tissues of mice.
Direct chemotaxis of PMN in response to encapsulated C. neoformans cells or to cryptococcal capsular polysaccharide has been assessed previously by other investigators but reported to be negative (8, 22, 29) . The difference between our conclusions and those of others may be attributable to several factors. The most probable reason for our concluding that C. neoformans has direct chemotactic effects on PMN, whereas others reported that C neoformans was not directly chemotactic for PMN, is based on the differences in controls used. In an earlier report of negative direct chemotaxis, chemotaxis of PMN to C. neoformans cells was compared with a control in which serum was the chemoattractant (22) . Sera from most species of animals and humans have been shown to have direct chemotactic activity (29, 37) ;-therefore, it is not appropriate to include serum in the negative control. Furthermore, Perez and Goldstein (28) reported that the heat-stable factors mediating chemotactic activity of PHS are CSa des Arg (C5a in which arginine has been cleaved from the COOH terminus) and its "cochemotaxin." Our data derived with HBSS as a negative control and demonstrating that PHS contained a heat-stable chemotactic factor(s) are in agreement with the observations of Perez and Goldstein (28) . Thus, comparisons of direct chemotactic activity of C. neoformans with a control such as PHS, which has chemotactic activity, would obscure any positive results and erroneous conclusions would be made. In the present study, we found that direct chemotactic activity of C. neofonnans cells was almost equal to the chemotactic activity of PHS, so had we used PHS as a negative control, we would have concluded, as did others (22), that C. neoformans has no direct chemotactic activity. However, using a more appropriate control, HBSS, we conclude just the opposite, that C. neoformans and, more specifically, GXM have direct chemotactic activity. The other potential reasons for our conclusions differing from those of others are probably less relevant than the reason just discussed, but those reasons should be mentioned. It is possible that factors such as different serotypes or strains of C neoformans used in the different studies contributed to differences. In addition, different assay techniques were used in our study, and cryptococcal polysaccharide preparations used in the different studies were purified differently. A careful search of the literature did not find any studies in which highly purified GXM had been assessed for direct and indirect chemotactic effects on human PMN. Therefore, this report is most likely the first to demonstrate that GXM has direct chemotactic activity, whereas MP does not, and that both GXM and MP can activate complement to produce a chemotactic factor. The cryptococcal polysaccharide preparations used by others (8, 22) were most likely mixtures of GXM, MP, and GalXM because similar preparations were used in the studies which defined the MP and GalXM from C. neoformans culture filtrates (5) . All of the above factors could have contributed to some degree to the disparate conclusions.
The fact that CneF-184A displays direct chemotactic activity for PMN is not unique to C. neofonnans. Other investigators have found that the culture filtrates of Candida albicans and Blastomyces derinatitidis also possess direct chemotactic activities for PMN (6, 35) . The factor responsible for direct chemotactic activity of the culture filtrate from B. dennatitidis is probably a carbohydrate or a glycoprotein (35) . Thus, it is not surprising that the high-molecular-weight polysaccharide, GXM, from the encapsulated cryptococcal cells was found to be the component responsible for the direct chemotactic activity.
Encapsulated and nonencapsulated cryptococcal cells and CneFs derived therefrom display indirect chemotactic activity for PMN. That is, cryptococcal cells and their CneFs can activate heat-labile components in serum to generate chemotactic factors for PMN. This ability of C. neofornans cells to activate serum to generate a chemotactic factor(s) for PMN is not a new observation. Laxalt and Kozel (22) , with a different chemotaxis assay system and a different source of PMN (rabbits), have shown previously that cryptococcal cells will activate serum to become chemotactic for PMN. Diamond and Erickson (8) identified the human serumderived chemotactic factor induced by C. neofonnans as being C5a. Recently, Kozel et al. (21) reported that both the cryptococcal capsule and the cell wall were powerful activators of the alternative complement pathway.
Our results show that GXM, which is definitely associated with the capsule, can activate a component(s) in serum to become chemotactic for PMN. Moreover, the components in the encapsulated cryptococcal cells responsible for activating serum to generate a chemotactic factor(s) are associated with the capsule as well as with exposed parts of the cell wall. Results of experiments with the acapsular isolate 602 indicate that a component(s) associated with the cell wall can stimulate the generation of a chemotactic factor(s) in PHS. By using purified MP from both CneF-184A and CneF-602 to activate PHS, we were able to show that MP can activate serum to generate a chemotactic factor(s) for PMN. We cannot exclude the possibility that other components present on 184A or 602 cells or in the culture filtrates may be able to activate serum to become chemotactic for PMN, but it is clear that GXM and MP have that ability. The direct and indirect chemotactic effects of GalXM on PMN could not be assessed because a sufficient amount of purified GalXM was not available. However, since CneF-602, which contains GalXM and MP, does not show any direct chemotactic activity, we can conclude that GalXM, at least in the concentration in CneF-602 and on the 602 cells, was not able to directly stimulate chemotaxis of PMN.
It has been reported that most of the chemotactic factors, such as CSa, FMLP, and the culture filtrate of B. dennatitidis, also possess chemokinetic activities (24, 35 As mentioned previously, the MP has been demonstrated to be the primary component recognized by the anticryptococcal cell-mediated immune response in mice (27) . Reiss et al. (30) have found antibodies to MP in the sera of patients with cryptococcosis. Considering our results, which show that MP prepared from both encapsulated and nonencapsulated C. neoformans can activate serum to generate a chemotactic factor(s), it is reasonable to speculate that MP along with GXM may be important in mediating the induction of a tissue response to C. neoformans or in mediating complement depletion in sera from individuals infected with C. neoformans.
Cryptococcal polysaccharide has been regarded as a prominent virulence factor for C. neoformans because it is antiphagocytic and induces suppression of anticryptococcal humoral and cell-mediated immune responses (2, 20, 26) . Cryptococcal polysaccharide can be detected in serum or cerebrospinal fluid of patients with cryptococcal meningitis, and its level is of diagnostic as well as prognostic value, with rising titers signifying a poor prognosis and falling titers indicating improvement (7) . Titers of cryptococcal polysaccharides in both cerebrospinal fluid and serum are enormously elevated in AIDS patients with cryptococcosis, frequently exceeding 1:100,000 (equivalent to approximately 1 mg of cryptococcal polysaccharide per ml) and going as high as 1:2,000,000 (11) . Such titers were unheard of prior to AIDS (11) . Because tissue responses to C. neoformans are usually minimal, particularly in brain and other infected tissues during disseminated disease, some investigators have attributed the lack of a strong inflammatory response to the presence of the capsular polysaccharide (12) . This concept, however, is not supported by the work of Laxalt and Kozel (1) , but chemotactic activities of a factor(s) derived from the activation of serum with C. neoformans or its CneF were relatively strong. Moreover, when the direct and indirect chemotactic factors were mixed, the resulting chemotactic activity was not additive for the two kinds of chemotactic factors tested separately. This was shown by the finding that when the chemotactic factors in heat-inactivated PHS (C5a des Arg and its cochemotaxin) were mixed with CneF-184A, the chemotactic activity of the mixture was equal to the chemotactic activity of the heat-inactivated PHS alone or the chemotactic activity of CneF-184A alone but not equivalent to the additive chemotactic activities of heat-inactivated PHS and CneF-184A. Considering that CneF-184A is composed mainly of GXM, we can eliminate the possibility that the increased chemotactic activity observed with GXM in PHS is due to additive chemotactic effects of GXM and PHS. Therefore, it is possible that in the presence of serum-derived chemotactic factor (i.e., C5a), C. neofonnans-derived chemotactic factor (i.e., GXM) is not effective in inducing migration of additional PMN because the strong chemotactic activity of the former masks the weak chemotactic activity of the latter. On the basis of the results presented here, we propose that the chemotactic factor(s) derived from serum activated by C. neoformans cells or by CneF may be a key mediator in inducing cellular infiltration into C. neofornans-infected tissues. The two different chemoattractants with different degrees of activity that are associated with C. neoformnans could be partially responsible for the variations observed in tissue responses to C. neoformans.
